drug development overview – large molecules...pharmaco- kinetics bio-analytical method vector...

1
Glycosylation: Activated sugars Enzymes: glycosidases and glycosyltransferases In-Process Control: Broad parameter menu Cedex Bio/Bio HT Analyzer Cedex HiRes Analyzer Cell Culture Harvest: Rec Trypsin DNase Glycosylation: Activated sugars Enzymes: glycosidases and glycotransferase Proteolysis: Rec Carboxypeptidase Rec Trypsin Endopeptidase Generic Reagents for Home-brew Assays 1-step RT-PCR: NxtScript RNA Master EvoScript RNA Master HawkZ05 Fast Master Mix 2-step RT-PCR: NxtScript 2G RT Transcriptor RT + KAPA3G HotStart Master In-Process Control: Broad parameter menu Cedex Bio/Bio HT Analyzer Cedex HiRes Analyzer Release Testing & QC: QC Sample Preparation Kit MycoTOOL Mycoplasma Real-Time PCR Kit MycoTOOL Mycoplasma Detection Amplification Kit Residual DNA E. coli Kit Residual DNA CHO Kit Residual Protein Trypsin Kit Residual Protein Liberase Kit Drug Development Overview – Large Molecules Target Assessment Lead Identification Preclinical Drug Development focuses on understanding the disease targets. Range: millions of compounds. involves the design or identification of compounds which have the capacity to activate or inhibit the actions of a target. Range: thousands of compounds. studies toxicity and pharmacokinetic behavior of the preclinical candidates in depth to select the clinical lead candidate. Range: hundreds of molecules in small scale. Up- and Downstream Development selects optimal cell line (out of hundreds) for the chosen molecule and develops best-performing bioprocesses for technology transfer to production. Analytic Development develops quality control and release tests. Production is in charge of high scale manufacturing under cGMP for market supply. Fermentation scales range from 200 – 16 000 liters. Target Identification and Validation Screening Hit and Lead Identification Lead Optimization Biomarkers are used as early indicators of efficacy and/or toxicity. They could accelerate clinical development or define a specific patient population where the proposed drug candidate shows the most optimal efficacy. Bio-Imaging is a specific part of biomarker research which visualizes the efficacy of a drug, shows progress of a disease or visualizes specific targets in in vitro and in vivo systems. Early Cell Line Deve- lopment and Small- Scale Manufacturing Preclinical Fermentation Purification Analytics Fermentation Purification QC Release Testing Disease Pathology In Vitro Subcellular Screening Isolation and Characterization In Vitro Cellular Screening “omics” Animal Models X-Ray Crystallography Molecular Modeling Structure- Activity Relationship Synthesis Absorption, Distribution, Metabolism and Excretion Libraries Natural Products Scaffolds Mechanism of Action/ Pharmacology Pharmaco- kinetics Bio-Analytical Method Vector Construction Preclinical Gene Sequence Confirmation Genetic Characterization Cell Line Selection Cell Line Stability Fermentation Process Post-Translational Modification Isolation of Target Molecule Bio-Marker Testing/ Bio- Imaging Tox Studies Pharma- cology Pharmaco- kinetics Cell Line Development Media Development Media Optimization Feed Optimization Cell Culture Harvest Affinity & Polishing Chromatography Viral Filtration Post-Translational Modification Ultra Filtration Bioburden Endotoxin Mycoplasma Virus Testing Residual Enzyme Testing Comparability Studies Host Cell DNA Fermentation Process Cell Culture Harvest Affinity & Polishing Chromatography Post-Translational Modification Viral Filtration Ultra Filtration Bioburden Endotoxin Mycoplasma Virus Testing Host Cell DNA Residual Enzyme Testing The use of the displayed products can be subject to regulatory or license constraints. Please consult the product specific information on custombiotech.roche.com for further details. Quality Control Analytical Research and Development Purity, Carbohydrate Analysis, Functional Assays, Protein Mass, Conformational Analysis, Aggregation Analysis, Process Residual Testing, etc. Technology Transfer Technology Transfer Clinical Trials Phases Commercialization Drug Discovery 1 2 3 Defined Production Process GMP Manufacturing Genotyping: AptaTaq Genotyping Master KAPA3G HotStart Master Mix Gene Expression: EvoScript RNA Master HawkZ05 Fast Master Mix NxtScript 2G RT + KAPA3G HotStart Master Process Development Non-GMP Development / GMP Manufacturing Quality by Design (QbD) Continuous Process Verification Process Validation Study

Upload: others

Post on 18-Sep-2020

7 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Drug Development Overview – Large Molecules...Pharmaco- kinetics Bio-Analytical Method Vector Construction Preclinical Gene Sequence Confirmation Genetic Characterization Cell Line

Glycosylation:• Activated sugars• Enzymes: glycosidases and

glycosyltransferases

In-Process Control:• Broad parameter menu• Cedex Bio/Bio HT Analyzer• Cedex HiRes Analyzer

Cell Culture Harvest:• Rec Trypsin • DNase

Glycosylation:• Activated sugars• Enzymes: glycosidases and

glycotransferase

Proteolysis:• Rec Carboxypeptidase• Rec Trypsin• Endopeptidase

Generic Reagents for Home-brew Assays

1-step RT-PCR:• NxtScript RNA Master • EvoScript RNA Master• HawkZ05 Fast Master Mix

2-step RT-PCR:• NxtScript 2G RT• Transcriptor RT + KAPA3G HotStart Master

In-Process Control:• Broad parameter menu• Cedex Bio/Bio HT Analyzer• Cedex HiRes Analyzer

Release Testing & QC:• QC Sample Preparation Kit• MycoTOOL Mycoplasma

Real-Time PCR Kit• MycoTOOL Mycoplasma

Detection Amplification Kit

• Residual DNA E. coli Kit• Residual DNA CHO Kit• Residual Protein Trypsin Kit • Residual Protein Liberase Kit

Drug Development Overview – Large Molecules

Target Assessment Lead Identification Preclinical Drug Development

focuses on understanding the disease targets. Range: millions of compounds.

involves the design or identification of compounds which have the capacity to activate or inhibit the actions of a target. Range: thousands of compounds.

studies toxicity and pharmacokinetic behavior of the preclinical candidates in depth to select the clinical lead candidate. Range: hundreds of molecules in small scale.

Up- and Downstream Development

selects optimal cell line (out of hundreds) for the chosen molecule and develops best-performing bioprocesses for technology transfer to production.

Analytic Development

develops quality control and release tests.

Production

is in charge of high scale manufacturing under cGMP for market supply. Fermentation scales range from 200 – 16 000 liters.

Target Identification and Validation

Screening Hit and Lead Identification

Lead Optimization

Biomarkers are used as early indicators of efficacy and/or toxicity. They could accelerate clinical development or define a specific patient population where the proposed drug candidate shows the most optimal efficacy.

Bio-Imaging is a specific part of biomarker research which visualizes the efficacy of a drug, shows progress of a disease or visualizes specific targets in in vitro and in vivo systems.

Early Cell Line Deve-lopment and Small-

Scale ManufacturingPreclinical Fermentation Purification Analytics Fermentation Purification QC Release

Testing

Disease Pathology

In Vitro Subcellular Screening

Isolation and Characterization

In Vitro Cellular Screening

“omics”

Animal Models

X-RayCrystallography

Molecular Modeling

Structure- Activity

Relationship

Synthesis Absorption, Distribution,

Metabolism and Excretion

Libraries

Natural Products

ScaffoldsMechanism of Action/

Pharmacology

Pharmaco- kinetics

Bio-Analytical Method

Vector Construction Preclinical

Gene Sequence Confirmation

Genetic Characterization

Cell Line Selection Cell Line Stability

Fermentation Process

Post-Translational Modification

Isolation of Target Molecule

Bio-Marker Testing/

Bio- Imaging

Tox Studies Pharma- cology

Pharmaco-kinetics

Cell Line Development

Media Development

Media Optimization

Feed Optimization

Cell Culture Harvest

Affinity & Polishing

Chromatography

Viral Filtration

Post-Translational Modification Ultra

Filtration

Bioburden

Endotoxin

Mycoplasma

Virus Testing

Residual Enzyme Testing

Comparability Studies

Host Cell DNA

Fermentation Process

Cell Culture Harvest

Affinity & Polishing

Chromatography

Post-Translational Modification

Viral Filtration

Ultra Filtration

Bioburden

Endotoxin

Mycoplasma

Virus Testing

Host Cell DNA

Residual Enzyme Testing

The use of the displayed products can be subject to regulatory or license constraints. Please consult the product specific information on custombiotech.roche.com for further details.

Quality Control

Analytical Research and DevelopmentPurity, Carbohydrate Analysis, Functional Assays, Protein Mass, Conformational Analysis, Aggregation Analysis, Process Residual Testing, etc.

Technology Transfer Technology Transfer

Clinical Trials Phases CommercializationDrug Discovery1 2 3

Defined Production Process GMP Manufacturing

Genotyping:• AptaTaq Genotyping Master• KAPA3G HotStart Master Mix

Gene Expression:• EvoScript RNA Master• HawkZ05 Fast Master Mix• NxtScript 2G RT + KAPA3G HotStart Master

Process DevelopmentNon-GMP Development / GMP Manufacturing

Quality by Design (QbD)

Continuous Process Verification Process Validation Study